Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-06-21

FDA Approved: RECTIV — Original Application (Allergan, Inc.)

View source ↗

Summary

FDA approved RECTIV (nitroglycerin) ointment in its original application for the treatment of chronic anal fissure, developed by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RECTIV (nitroglycerin)

Snippet

ORIG AP for RECTIV (NITROGLYCERIN)